1,2-Naphthoquinone disrupts the function of cAMP response element-binding protein through covalent modification

Biochemical and Biophysical Research Communications

Volumn 361, Issue 1, 2007, Pages 243-248

  Endo, Akiko ^a   Sumi, Daigo ^a   Kumagai, Yoshito ^a,b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bcl 2; CREB; Electrophile; Quinone

Indexed keywords

1,2 NAPHTHOQUINONE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DITHIOTHREITOL; HYDROCARBON; LUCIFERASE; NAPHTHALENE; PROTEIN BCL 2;

ANIMAL CELL; ARTICLE; CELL FREE SYSTEM; CONTROLLED STUDY; COVALENT BOND; COW; DNA BINDING; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION;

AIR POLLUTANTS; ANIMALS; CATTLE; CELLS, CULTURED; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DNA; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; NAPHTHOQUINONES; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSCRIPTION, GENETIC;

BOVINAE;

EID: 34547133038     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.07.024     Document Type: Article

References (30)

1. Bolton J.L., Trush M.A., Penning T.M., Dryhurst G., and Monks T.J. Role of quinones in toxicology. Chem. Res. Toxicol. 13 (2000) 135-160
2. 2.5. Aerosol. Sci. Technol. 38 (2004) 1-14
3. Kim E.H., and Surh Y.J. 15-deoxy-Delta12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors. Biochem. Pharmacol. 72 (2006) 1516-1528
4. Kim H.J., Kim J.Y., Meng Z., Wang L.H., Liu F., Conrads T.P., Burke T.R., Veenstra T.D., and Farrar W.L. 15-deoxy-Delta12,14-prostaglandin J2 inhibits transcriptional activity of estrogen receptor-alpha via covalent modification of DNA-binding domain. Cancer Res. 67 (2007) 2595-2602
5. Mayr B., and Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol. 2 (2001) 599-609
6. Taylor C.T., Fueki N., Agah A., Hershberg R.M., and Colgan S.P. Critical role of cAMP response element binding protein expression in hypoxia-elicited induction of epithelial tumor necrosis factor-alpha. J. Biol. Chem. 274 (1999) 19447-19454
7. Muller F.U., Neumann J., and Schmitz W. Transcriptional regulation by cAMP in the heart. Mol. Cell Biochem. 212 (2000) 11-17
8. Xie S., Price J.E., Luca M., Jean D., Ronai Z., and Bar-Eli M. Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells. Oncogene 15 (1997) 2069-2075
9. Abramovitch R., Tavor E., Jacob-Hirsch J., Zeira E., Amariglio N., Pappo O., Rechavi G., Galun E., and Honigman A. A pivotal role of cyclic AMP-responsive element binding protein in tumor progression. Cancer Res. 64 (2004) 1338-1346
10. Tully T., Bourtchouladze R., Scott R., and Tallman J. Targeting the CREB pathway for memory enhancers. Nat. Rev. Drug Discov. 2 (2003) 267-277
11. Chrivia J.C., Kwok R.P., Lamb N., Hagiwara M., Montminy M.R., and Goodman R.H. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365 (1993) 855-859
12. Wang Z., Zhang B., Wang M., and Carr B.I. Persistent ERK phosphorylation negatively regulates cAMP response element-binding protein (CREB) activity via recruitment of CREB-binding protein to pp90RSK. J. Biol. Chem. 278 (2003) 11138-11144
13. Gonzalez G.A., Yamamoto K.K., Fischer W.H., Karr D., Menzel P., Biggs III W., Vale W.W., and Montminy M.R. A cluster of phosphorylation sites on the cyclic AMP-regulated nuclear factor CREB predicted by its sequence. Nature 337 (1989) 749-752
14. Abate C., Patel L., Rauscher III F.J., and Curran T. Redox regulation of fos and jun DNA-binding activity in vitro. Science 249 (1990) 1157-1161
15. Vinson C., Acharya A., and Taparowsky E.J. Deciphering B-ZIP transcription factor interactions in vitro and in vivo. Biochim. Biophys. Acta 1759 (2006) 4-12
16. Perez-Sala D., Cernuda-Morollon E., and Canada F.J. Molecular basis for the direct inhibition of AP-1 DNA binding by 15-deoxy-Delta 12,14-prostaglandin J2. J. Biol. Chem. 278 (2003) 51251-51260
17. Bloom D., Dhakshinamoorthy S., and Jaiswal A.K. Site-directed mutagenesis of cysteine to serine in the DNA binding region of Nrf2 decreases its capacity to upregulate antioxidant response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene. Oncogene 21 (2002) 2191-2200
18. Zheng J., and Hammock B.D. Development of polyclonal antibodies for detection of protein modification by 1,2-naphthoquinone. Chem. Res. Toxicol. 9 (1996) 904-909
19. Goren I., Tavor E., Goldblum A., and Honigman A. Two cysteine residues in the DNA-binding domain of CREB control binding to CRE and CREB-mediated gene expression. J. Mol. Biol. 313 (2001) 695-709
20. Troester M.A., Lindstrom A.B., Waidyanatha S., Kupper L.L., and Rappaport S.M. Stability of hemoglobin and albumin adducts of naphthalene oxide, 1,2-naphthoquinone, and 1,4-naphthoquinone. Toxicol. Sci. 68 (2002) 314-321
21. Waidyanatha S., Troester M.A., Lindstrom A.B., and Rappaport S.M. Measurement of hemoglobin and albumin adducts of naphthalene-1,2-oxide, 1,2-naphthoquinone and 1,4-naphthoquinone after administration of naphthalene to F344 rats. Chem. Biol. Interact. 141 (2002) 189-210
22. Deak M., Clifton A.D., Lucocq L.M., and Alessi D.R. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. Embo. J. 17 (1998) 4426-4441
23. Du K., and Montminy M. CREB is a regulatory target for the protein kinase Akt/PKB. J. Biol. Chem. 273 (1998) 32377-32379
24. Matthews R.P., Guthrie C.R., Wailes L.M., Zhao X., Means A.R., and McKnight G.S. Calcium/calmodulin-dependent protein kinase types II and IV differentially regulate CREB-dependent gene expression. Mol. Cell Biol. 14 (1994) 6107-6116
25. Sun P., Enslen H., Myung P.S., and Maurer R.A. Differential activation of CREB by Ca2+/calmodulin-dependent protein kinases type II and type IV involves phosphorylation of a site that negatively regulates activity. Genes Dev. 8 (1994) 2527-2539
26. Tan Y., Rouse J., Zhang A., Cariati S., Cohen P., and Comb M.J. FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. Embo. J. 15 (1996) 4629-4642
27. Xing J., Ginty D.D., and Greenberg M.E. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 273 (1996) 959-963
28. Yamamoto K.K., Gonzalez G.A., Biggs III W.H., and Montminy M.R. Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature 334 (1988) 494-498
29. Murphy K.M., Ranganathan V., Farnsworth M.L., Kavallaris M., and Lock R.B. Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells. Cell Death Differ. 7 (2000) 102-111
30. Watanabe T., Zhang N., Liu M., Tanaka R., Mizuno Y., and Urabe T. Cilostazol protects against brain white matter damage and cognitive impairment in a rat model of chronic cerebral hypoperfusion. Stroke 37 (2006) 1539-1545